Improved Risk Models Identify People at Higher than Normal Risk of Pancreatic Cancer

Researchers demonstrated that risk models that include established clinical, genetic, and circulating factors are better able to identify people at significantly higher than normal risk of pancreatic cancer over those using clinical factors alone.

Alterations in Genitourinary Cancer Care Due to COVID-19

In a webinar, a multidisciplinary team from Duke Cancer Center came together to discuss the differences in treating patients with genitourinary cancer as a result of the COVID-19 pandemic.

Hypercalcemia at DLBCL Diagnosis May Be Associated with Adverse Impacts

Hypercalcemia at diagnosis of diffuse large B-cell lymphoma was found to be strongly correlated with adverse prognostic factors and a short diagnosis-to-treatment interval.